Acute Lymphoblastic Leukemia: Risk Stratification
2 vistas
• 06/15/23
0
0
Empotrar
administrator
Suscriptores
Mark R. Litzow, MD; Ryan D. Cassaday, MD; Aaron C. Logan, MD, PhD; Bijal D. Shah, MD; and Anthony S. Stein, MD, reflect on the complexities of the risk stratification process in acute lymphoblastic leukemia, incorporating patient age, molecular subtype, and minimal residual disease status.
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios